Skip to search
Skip to main content
Back to Search
Start Over
A phase 2 study of a novel transforming growth factor-beta (TGF-beta 1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC)
Authors :
Faivre, Sandrine J. Santoro, Armando Kelley, Robin Kate Merle, Philippe Gane, Ed Douillard, Jean-Yves Waldschmidt, Dirk Mulcahy, Mary Frances Costentin, Charlotte Minguez, Beatriz Papappicco, Pasqua Gueorguieva, Ivelina Cleverly, Ann Desaiah, Durisala Lahn, Michael M. Ameryckx, Sophie Benhadji, Karim A. Raymond, Eric Giannelli, Gianluigi Faivre, Sandrine J. Santoro, Armando Kelley, Robin Kate Merle, Philippe Gane, Ed Douillard, Jean-Yves Waldschmidt, Dirk Mulcahy, Mary Frances Costentin, Charlotte Minguez, Beatriz Papappicco, Pasqua Gueorguieva, Ivelina Cleverly, Ann Desaiah, Durisala Lahn, Michael M. Ameryckx, Sophie Benhadji, Karim A. Raymond, Eric Giannelli, Gianluigi
Publication Year :
2014
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1247376047
Document Type :
Electronic Resource